Neuren Pharmaceuticals Limited (ASX:NEU)
Australia
· Delayed Price · Currency is AUD 11.68
-0.67 (-5.43%)
At close: Mar 9, 2026
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 1.48 billion as of March 9, 2026. Its market cap has decreased by -12.27% in one year.
Market Cap
1.48B
Enterprise Value
1.18B
Revenue
64.65M
Ranking
n/a
PE Ratio
50.19
Stock Price
11.68
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 1.48B, an increase of 6,966.11%. That is a compound annual growth rate of 22.36%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PYC Therapeutics | 1.46B |
| Clarity Pharmaceuticals | 1.33B |
| Mesoblast | 2.97B |
| Opthea | 738.77M |
| Telix Pharmaceuticals | 3.64B |
| Immutep | 582.12M |
| Clinuvel Pharmaceuticals | 510.04M |
| Racura Oncology | 446.99M |